Forty-three percent of CMOs and oncology leaders are currently implementing a precision medicine program at their organization, according to a survey conducted by The Health Management Academy.
The academy curated responses from 21 CMOs and oncology leaders that operate or own 296 hospitals to determine their awareness, integration and operationalization of precision medicine.
Here are four survey insights.
1. Ten percent of respondents indicated their organization already implemented a precision medicine program that has been active for at least one year.
2. The majority (60 percent) of health systems are developing a precision medicine program, which they deem is a high (25 percent) or essential (35 percent) priority at their organization.
3. Sixty percent of respondents said their health system is involved in a cancer data-sharing collaboration.
4. In oncology, 89 percent of respondents expect precision medicine to improve patient outcomes, help enroll and retain patients and assist with clinical trial accrual.
More articles on data analytics & precision medicine:
Tempus, OHSU Knight Cancer Institute team up in cancer initiative
Inova partners with Veritas Genetics for whole genome sequencing, interpretation